1. Home
  2. BNT vs VTRS Comparison

BNT vs VTRS Comparison

Compare BNT & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNT
  • VTRS
  • Stock Information
  • Founded
  • BNT 2020
  • VTRS 1961
  • Country
  • BNT Bermuda
  • VTRS United States
  • Employees
  • BNT N/A
  • VTRS N/A
  • Industry
  • BNT
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • BNT
  • VTRS Health Care
  • Exchange
  • BNT Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • BNT 14.1B
  • VTRS 12.0B
  • IPO Year
  • BNT N/A
  • VTRS N/A
  • Fundamental
  • Price
  • BNT $45.94
  • VTRS $10.58
  • Analyst Decision
  • BNT
  • VTRS Hold
  • Analyst Count
  • BNT 0
  • VTRS 6
  • Target Price
  • BNT N/A
  • VTRS $11.17
  • AVG Volume (30 Days)
  • BNT 31.0K
  • VTRS 9.8M
  • Earning Date
  • BNT 11-13-2025
  • VTRS 11-06-2025
  • Dividend Yield
  • BNT 0.53%
  • VTRS 4.54%
  • EPS Growth
  • BNT 0.15
  • VTRS N/A
  • EPS
  • BNT 4.29
  • VTRS N/A
  • Revenue
  • BNT $14,328,000,000.00
  • VTRS $14,124,400,000.00
  • Revenue This Year
  • BNT N/A
  • VTRS N/A
  • Revenue Next Year
  • BNT N/A
  • VTRS $1.61
  • P/E Ratio
  • BNT $10.51
  • VTRS N/A
  • Revenue Growth
  • BNT 35.36
  • VTRS N/A
  • 52 Week Low
  • BNT $29.13
  • VTRS $6.85
  • 52 Week High
  • BNT $49.44
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • BNT 46.86
  • VTRS 53.02
  • Support Level
  • BNT $43.46
  • VTRS $10.15
  • Resistance Level
  • BNT $44.85
  • VTRS $11.28
  • Average True Range (ATR)
  • BNT 1.10
  • VTRS 0.38
  • MACD
  • BNT 0.69
  • VTRS -0.03
  • Stochastic Oscillator
  • BNT 84.80
  • VTRS 48.90

About BNT Brookfield Wealth Solutions Ltd.

Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: